SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-205404
Filing Date
2019-07-29
Accepted
2019-07-29 16:05:56
Documents
3
Period of Report
2019-07-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d758122d8k.htm 8-K 23797
2 EX-10.1 d758122dex101.htm EX-10.1 35763
3 EX-10.2 d758122dex102.htm EX-10.2 121716
  Complete submission text file 0001193125-19-205404.txt   182706
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38871 | Film No.: 19981223
SIC: 2834 Pharmaceutical Preparations